Paul DreierCEO at Novilytic. LLC
Dreier has been focused on software, technology, instrumentation, and PAT from the beginning of his career as a bench chemist. These efforts expanded into product and project management for the development of automated reactors for Pharmaceutical Process R&D at Camile Products, Argonaut Technologies, Biotage, and now Novilytic. Utilizing software developed by his Team, Dreier led the integration of PAT into various sizes of pharmaceutical reactors and bioreactors. He also led the Team who developed the first commercially integrated a liquid chromatograph with plural reactor systems in process R&D. Dreier has also lead multiple groups and teams internationally and been the founder and/or equity partner of five companies.
Interactive Panel Discussion - What do the Vendors Need to do Regarding Continuous? Picking Up the Slack and Filling in the Gaps, 3:00pmView Session
Continuous Process Validation (CPV): A New Analytical Strategy, 11:30amView Session